Performance of an RNA-Based Next-Generation Sequencing Assay for Combined Detection of Clinically Actionable Fusions and Hotspot Mutations in NSCLC

INTRODUCTION: With its expanding list of approved and emerging therapeutic indications, NSCLC is the exemplar tumor type requiring upfront assessment of several biomarkers to guide clinical management. Next-generation sequencing allows identification of different types of molecular alterations, each...

Descripción completa

Detalles Bibliográficos
Autores principales: Desmeules, Patrice, Boudreau, Dominique K., Bastien, Nathalie, Boulanger, Marie-Chloé, Bossé, Yohan, Joubert, Philippe, Couture, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888203/
https://www.ncbi.nlm.nih.gov/pubmed/35252895
http://dx.doi.org/10.1016/j.jtocrr.2022.100276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888203/
https://www.ncbi.nlm.nih.gov/pubmed/35252895
http://dx.doi.org/10.1016/j.jtocrr.2022.100276

Ejemplares similares